Third bridge toward indefinite human lifespans — achieved via synergy of AI and advanced nanotechnology — occurs in the 2030s; once AGI crosses into superintelligence, it will solve fundamental mechanisms of biological decay, leading to worldwide eradi...
Predictor: Nick Bostrom
Prediction text
Third bridge toward indefinite human lifespans — achieved via synergy of AI and advanced nanotechnology — occurs in the 2030s; once AGI crosses into superintelligence, it will solve fundamental mechanisms of biological decay, leading to worldwide eradication of diseases like malaria and Alzheimer's, and eventually push humanity toward biological immortality + brain-to-brain mental transfer capabilities. | ASI-to-nanotech breakthrough combination event
Key catalyst: ASI-to-nanotech breakthrough combination event
Watch events: First nanotech-bloodstream clinical deployment; ASI emergence
Resolution evidence
Bostrom "Death of Death" framework + Superintelligence foundational; 2030s indefinite lifespan requires ASI + nanotech breakthroughs.
Predictor: Nick Bostrom
Evidence about this node from Nick Bostrom is multiplied by κ in /api/intake. Lower κ = less weight; floors at 0.10 (effectively silenced) and caps at 1.00 (full weight).
Reference class: agi_breakthrough_5y
Major capability discontinuity (e.g. AGI by named target year, 5-year horizon)
Tetlock-style outside view: at TRF=1 (just predicted), outside view dominates (w_in=0.3). At TRF=0 (deadline), inside view dominates (w_in=1.0). The blend regularizes overconfident inside views toward the historical base rate.
Probability over time
Milestone chain
- 2028-06-01 → 2031-12-31pendingAGI declared / Kurzweil 2029 AGI threshold validated by independent benchmarksHow: Major frontier lab (OpenAI, Anthropic, DeepMind) declares AGI achievement and >=2 independent benchmark consortia (e.g., METR, ARC, GAIA) confirm human-level performance across >=80% of cognitive domainsSource: Kurzweil 2029 AGI prediction (Singularity Is Nearer)conf 55%
- 2029-01-01 → 2031-12-31pendingLongevity escape velocity reachable for diligent/informed individuals (Kurzweil 'Bridge 2' threshold)How: Peer-reviewed actuarial or NIA-tracked study shows healthy adults gaining >=1 year of life expectancy per calendar year via combined biotech/AI interventions (epigenetic reprogramming, senolytics, AI drug discovery)Source: Kurzweil 'The Singularity is Nearer' (2024) — Bridge 2 longevity escape velocity, ~2030conf 45%
- 2031-08-23pendingQ1 window check-in (25%)
- 2030-01-01 → 2034-06-30pendingFirst in-human medical nanorobot trial cleared by FDA or comparable regulatorHow: FDA IND or EMA equivalent approval for Phase I clinical trial of programmable nanoscale therapeutic device (DNA origami, magnetic nanobot, or molecular-machine class) for in-vivo diagnostic or therapeutic interventionSource: Kurzweil Bridge 3 nanotech medical robotics 2030sconf 35%
- 2033-04-14pendingQ2 window check-in (50%)
- 2034-12-05pendingQ3 window check-in (75%)
- 2032-01-01 → 2037-12-31pendingWHO declares one major age-related disease (Alzheimer's or one cancer subtype) effectively eliminated as cause of death in OECDHow: WHO Global Health Estimates report shows >=90% reduction in age-adjusted mortality attributable to a previously top-10 disease across OECD countries, attributed to AI-driven drug discovery + targeted therapeuticsSource: Kurzweil end-of-2030s disease eradication thesisconf 25%
- 2034-01-01 → 2040-12-31pendingAverage OECD life expectancy at birth crosses 90 yearsHow: OECD Health Statistics or UN Population Division reports population-weighted life expectancy at birth across OECD-38 >=90.0 yearsSource: Implication of Bridge 2 + Bridge 3 + AI drug discovery convergenceconf 20%
- 2035-01-01 → 2040-12-31pendingFirst brain-to-brain or whole-brain emulation demonstration peer-reviewedHow: Peer-reviewed publication (Nature/Science/Cell tier) demonstrating bidirectional digital information transfer between two human brains via implanted/non-invasive interface, OR successful emulation of complete mammalian connectome with functional behavioral paritySource: Kurzweil mind-uploading / brain-merge thesisconf 15%
What if this resolves?
Click a button to clamp this prediction and run a Gibbs sample. Returns the predictions whose marginals shift most. ~30s per run; ideal for stress-testing "if X resolves, what else moves?"
Evidence chain
Network propagation neighbors
Top incoming (parents)
Edges that influence THIS node's belief
Top outgoing (children)
Predictions THIS node influences
No outgoing edges.
Prerequisites (4)
| Type | Pred | Title | Domain | Lag |
|---|---|---|---|---|
| correlate | S_ASI_SLOW_2040PLUS | ASI slow: post-2040 / soft takeoff | asi_recursive_self_improvement | — |
| correlate | S_AGI_MID_2029 | AGI mid: Kurzweil 2029 path | agi_general_capability | — |
| killer | TK01 | AGI Capability Plateau (2026-27 Training Stall) | — | — |
| killer | TK03 | AI Regulatory Moratorium (EU/US Capability Freeze) | — | — |
Dependents (0)
| Type | Pred | Title | Domain | Lag |
|---|---|---|---|---|
| No dependents | ||||
Raw metadata
{
"nia": false,
"qty": "indefinite lifespan + malaria/Alzheimer eradication",
"mode": "FORECAST",
"role": "Cited-Other",
"context": "Sixth Bostrom entry (232_040 pause, AI_035 meaning of life, CYB_027 orthogonality, ROB_027 paperclip embodied, AUT_025 Deep Utopia). Specific 'third bridge' framing + 2030s immortality timeline.",
"to_year": 2039,
"conv_cues": "philosopher FIRST_PERSON; framework nomenclature",
"direction": "HAPPEN",
"from_year": 2030,
"timeframe": "2030-2039",
"conv_level": "HIGH",
"milestones": [
{
"kind": "scenario_signal",
"label": "Scenario fires: AGI mid: Kurzweil 2029 path",
"status": "pending",
"weight": 0.3,
"ordinal": -8,
"source_id": "S_AGI_MID_2029",
"expected_date": "2029-03-31",
"observed_date": null
},
{
"kind": "llm_pre_event",
"label": "AGI declared / Kurzweil 2029 AGI threshold validated by independent benchmarks",
"source": "Kurzweil 2029 AGI prediction (Singularity Is Nearer)",
"status": "pending",
"weight": 0.4,
"ordinal": -7,
"source_id": null,
"confidence": 0.55,
"source_url": "https://medium.com/@rohitlokwani17/ai-immortality-and-the-future-of-humanity-from-kurzweils-the-singularity-is-nearer-a280ab0366be",
"expected_date": "2030-03-17",
"research_origin": "training",
"expected_date_range": {
"to": "2031-12-31",
"from": "2028-06-01"
},
"measurement_criterion": "Major frontier lab (OpenAI, Anthropic, DeepMind) declares AGI achievement and >=2 independent benchmark consortia (e.g., METR, ARC, GAIA) confirm human-level performance across >=80% of cognitive domains"
},
{
"kind": "llm_pre_event",
"label": "Longevity escape velocity reachable for diligent/informed individuals (Kurzweil 'Bridge 2' threshold)",
"source": "Kurzweil 'The Singularity is Nearer' (2024) — Bridge 2 longevity escape velocity, ~2030",
"status": "pending",
"weight": 0.4,
"ordinal": -6,
"source_id": null,
"confidence": 0.45,
"source_url": "https://fortune.com/well/article/a-i-radically-lengthen-lifespan-ray-kurzweil/",
"expected_date": "2030-07-02",
"research_origin": "training",
"expected_date_range": {
"to": "2031-12-31",
"from": "2029-01-01"
},
"measurement_criterion": "Peer-reviewed actuarial or NIA-tracked study shows healthy adults gaining >=1 year of life expectancy per calendar year via combined biotech/AI interventions (epigenetic reprogramming, senolytics, AI drug discovery)"
},
{
"kind": "quartile_checkpoint",
"label": "Q1 window check-in (25%)",
"status": "pending",
"weight": 0.05,
"ordinal": -5,
"source_id": null,
"expected_date": "2031-08-23",
"observed_date": null
},
{
"kind": "llm_pre_event",
"label": "First in-human medical nanorobot trial cleared by FDA or comparable regulator",
"source": "Kurzweil Bridge 3 nanotech medical robotics 2030s",
"status": "pending",
"weight": 0.4,
"ordinal": -4,
"source_id": null,
"confidence": 0.35,
"source_url": "https://thedebrief.org/futurist-predicts-humans-will-soon-live-1000-years-thanks-to-nanobots-and-ai/",
"expected_date": "2032-03-31",
"research_origin": "training",
"expected_date_range": {
"to": "2034-06-30",
"from": "2030-01-01"
},
"measurement_criterion": "FDA IND or EMA equivalent approval for Phase I clinical trial of programmable nanoscale therapeutic device (DNA origami, magnetic nanobot, or molecular-machine class) for in-vivo diagnostic or therapeutic intervention"
},
{
"kind": "quartile_checkpoint",
"label": "Q2 window check-in (50%)",
"status": "pending",
"weight": 0.05,
"ordinal": -3,
"source_id": null,
"expected_date": "2033-04-14",
"observed_date": nu
... (truncated)